Zobrazeno 1 - 10
of 501
pro vyhledávání: '"Su S. Chen"'
Autor:
Bettzy Stephen, Jansina Y. Fok, John V. Heymach, David S. Hong, Apostolia Maria Tsimberidou, Razelle Kurzrock, Su S. Chen, Jennifer J. Wheler, Gerald S. Falchook, Aung Naing, Filip Janku, Siqing Fu, Sarina Anne Piha-Paul
Publikováno v:
Oncotarget
Oncotarget, vol 4, iss 5
Oncotarget, vol 4, iss 5
// Jennifer Wheler 1 , Gerald Falchook 1 , Apostolia M. Tsimberidou 1 , David Hong 1 , Aung Naing 1 , Sarina Piha-Paul 1 , Su S. Chen 2 , John Heymach 3 , Siqing Fu 1 , Bettzy Stephen 1 , Jansina Y. Fok 1 , Filip Janku 1 , Razelle Kurzrock 4 1 Depart
Autor:
Lynne V. Abruzzo, Rashmi Kanagal-Shamanna, Su S. Chen, Carlos E. Bueso-Ramos, Marcos de Lima, Gary Lu, Rachel L. Sargent, L. Jeffrey Medeiros
Publikováno v:
Journal of Hematopathology. 6:25-32
Autor:
Su S. Chen, Jeffrey L. Jorgensen
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 11:S49-S53
Posttherapy minimal residual disease assessment in acute myeloid leukemia is an important prognostic indicator as well as a potential early surrogate measure of therapeutic effectiveness. The goal of this brief review is to discuss the broad classes
Publikováno v:
American Journal of Clinical Pathology. 135:391-397
del(20q) can be observed in hematologic neoplasms, including chronic myelogenous leukemia (CML), and has been reported in patients undergoing blast transformation. We describe 10 patients with CML in hematologic and cytogenetic remission with del(20q
Autor:
Ying Hu, Bo Feng, Su S. Chen, Sa A. Wang, Dan Jones, Jeffrey L. Jorgensen, L. Jeffrey Medeiros
Publikováno v:
Modern Pathology. 23:284-295
Peripheral blood involvement has been recognized as an adverse prognostic factor in patients with mycosis fungoides and Sezary syndrome. However, accurate identification and enumeration of the neoplastic cells in these diseases can be challenging. We
Autor:
Patrick A. Lennon, Srdan Verstovsek, Su S. Chen, Bedia A. Barkoh, John Galbincea, Peter Hu, Laura Millecker, Dan Jones
Publikováno v:
Cancer Genetics and Cytogenetics. 197:1-7
Chronic myeloproliferative neoplasms (MPN), including essential thrombocythemia (ET) and primary myelofibrosis (PMF), result from interactions between initiating growth factor mutations and secondary genomic changes. Codon 617 mutation of the JAK2 ki
Autor:
Su S. Chen, Bedia A. Barkoh, Madan G. Luthra, Asif Rashid, Russell Broaddus, Dipen M. Maru, Joe Ensor, Angela Romans, Yisheng Li, Rajesh R. Singh, Christina Hannah, Rajyalakshmi Luthra, Constance Albarracin
Publikováno v:
Oncogene. 27:6667-6678
Suppression of annexin A1 (ANXA1), a mediator of apoptosis and inhibitor of cell proliferation, is well documented in various cancers but the underlying mechanism remains unknown. We investigated whether decreased ANXA1 expression was mediated by mic
Publikováno v:
Molecular Pathology Library ISBN: 9781493928606
Molecular tests used by practicing pathologists are mostly performed on formalin-fixed, paraffin-embedded tissue specimens. Occasionally, when a more comprehensive molecular analysis is required, the use of fresh tissue or cell suspensions can overco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80bfeeadab0b369bfe9235efd35b765d
https://doi.org/10.1007/978-1-4939-2861-3_2
https://doi.org/10.1007/978-1-4939-2861-3_2
Autor:
Alexander J. Lazar, Raphael E. Pollock, Jonathan C. Trent, Dan Yang, Wei-Lein Wang, Su S Chen, Sabrina Pricl, Giovanni M. Pavan, John C. McAuliffe
Publikováno v:
Molecular Oncology. 2:161-163
Gastrointestinal stromal tumor (GIST) represents the majority of soft tissue sarcomas arising from the GI tract. Most GISTs encode activating mutations in the kit gene, an important genetic event in tumorigenesis. Imatinib mesylate (imatinib, Gleevec
Autor:
Jean Nicolas Vauthey, Dipen M. Maru, Scott Kopetz, Steven A. Curley, Thomas A. Aloia, Giuseppe Zimmitti, Su S. Chen, Andreas Andreou, Junichi Shindoh
Publikováno v:
Annals of surgery, vol 258, iss 4
ObjectiveTo determine the impact of RAS mutation status on survival and patterns of recurrence in patients undergoing curative resection of colorectal liver metastases (CLM) after preoperative modern chemotherapy.BackgroundRAS mutation has been repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7763109536d2c99235a7a3fbd7ea9803
https://escholarship.org/uc/item/1gj71760
https://escholarship.org/uc/item/1gj71760